Comparative Cytochrome P450-1A1, -2A6, -2B6, -2C, -2D6, -2E1, -3A5 and -4B1 expressions in human larynx tissue analysed at mRNA level

被引:16
作者
Sarikaya, Devrim
Bilgen, Cem
Kamataki, Tetsuya
Topcu, Zeki [1 ]
机构
[1] Ege Univ, Dept Pharmaceut Biotechnol, Fac Pharm, TR-35100 Izmir, Turkey
[2] Ege Univ, Dept Bioengn, Fac Engn, TR-35100 Izmir, Turkey
[3] Ege Univ, Fac Med, Dept Otorhinolaryngol, TR-35100 Izmir, Turkey
[4] Hokkaido Univ, Grad Sch Pharmaceut Sci, Lab Drug Metab, Sapporo, Hokkaido 0600812, Japan
关键词
cytochrome P450; laryngeal tissue; drug metabolizing enzymes;
D O I
10.1002/bdd.518
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The metabolic activation of numerous exogenous and endogenous chemicals is catalysed by cytochrome P450 enzymes (CYPs). The aim of this study was to analyse the expression of the individual forms of CYP at the mRNA level in human larynx and quantitatively to compare their expressions in human liver, the main in organ of CYP expression. Individual forms of CYP mRNAs were detected by reverse transcriptase-polymerase chain reaction (RT-PCR) using specific primers for the CYPs -1A1, -1A2, -2A6,-2B6,-2C, -2D6, -2E1, -3A3/4 ,-3A5, -3A7 and 4B1. An RNA competitor of known copy number, covering the primer sequences necessary to amplify the entire object CYPs within a single molecule, was used as reference. This study reports a consistent detection of mRNAs for the CYPs -1A1, -2A6, -2B6, -2C, -2D6, -2E1, -3A5 and -4B1 in the human larynx tissue. The data indicate that the human larynx highly resembles the lung tissue in CYP content, as a comparable subset of CYP mRNAs was detected in the larynx previously reported for human lung with the exception of CYP1A2. The results are discussed in quantitative ratios of the detected CYP mRNAs in relation to the hepatic CYP expression. Copyright (c) 2006 John Wiley & Sons, Ltd.
引用
收藏
页码:353 / 359
页数:7
相关论文
共 30 条
[1]  
[Anonymous], IARC SCI PUBL
[2]   Expression and localization of CYP3A4 and CYP3A5 in human lung [J].
Anttila, S ;
Hukkanen, J ;
Hakkola, J ;
Stjernvall, T ;
Beaune, P ;
Edwards, RJ ;
Boobis, AR ;
Pelkonen, O ;
Raunio, H .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1997, 16 (03) :242-249
[3]   Measurement of cytochrome P450 2A6 and 2E1 gene expression in primary human bronchial epithelial cells [J].
Crawford, EL ;
Weaver, DA ;
DeMuth, JP ;
Jackson, DM ;
Khuder, SA ;
Frampton, MW ;
Utell, MJ ;
Thilly, WG ;
Willey, JC .
CARCINOGENESIS, 1998, 19 (10) :1867-1871
[4]   Human extrahepatic cytochromes P450: Function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts [J].
Ding, XX ;
Kaminsky, LS .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2003, 43 :149-173
[5]  
Ekins S, 1998, J PHARMACOL EXP THER, V286, P1253
[6]   CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma [J].
Gajecka, M ;
Rydzanicz, M ;
Jaskula-Sztul, R ;
Kujawski, M ;
Szyfter, W ;
Szyfter, K .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2005, 574 (1-2) :112-123
[7]   Human CYP2B6: expression, inducibility and catalytic activities [J].
Gervot, L ;
Rochat, B ;
Gautier, JC ;
Bohnenstengel, F ;
Kroemer, H ;
de Berardinis, V ;
Martin, H ;
Beaune, P ;
de Waziers, I .
PHARMACOGENETICS, 1999, 9 (03) :295-306
[8]   Clinical relevance of genetic polymorphisms in the human CYP2C subfamily [J].
Goldstein, JA .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 52 (04) :349-355
[9]   HUMAN CYTOCHROMES-P450 - PROBLEMS AND PROSPECTS [J].
GONZALEZ, FJ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (09) :346-352
[10]  
GUENGERICH FP, 2002, CYTOCHROME P450, P33